This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • PEACE-3 Trial
      • PROfound Trial
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • VISION Trial
    • mHSPC
      • ARANOTE Trial
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • nmCSPC
      • EMBARK Trial
    • PSMA PET Imaging
      • COBRA Trial
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • ANKTIVA
      • Bladder Cancer Detection
      • CORE-001 Study
      • EV-302
    • Kidney Cancer
      • ZIRCON
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Health Policy
          • Health Policy
            Ruchika Talwar, MD
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Shilpa Gupta, MD
          • Trimodality Therapy
            Leslie Ballas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
        • Endourology
          • Endourology
            Jaime Landman, MD
      • Prostate Cancer
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • Decipher Genomic Classifier
        • Imaging Center
          Phillip Koo, MD
        • mHSPC
          Neeraj Agarwal, FASCO, MD
        • nmCRPC
          Zachary Klaassen, MD, MSc
        • mCRPC Treatment
          A. Oliver Sartor, MD
        • PSMA-Targeted Therapy
        • Advanced Prostate Cancer
          Zachary Klaassen, MD, MSc
      • Disparities: Social Determinants of Health
        • Disparities: Social Determinants of Health
          Samuel L. Washington III, MD, MAS
      • Translational Prostate Cancer
        • Translational Science in Prostate Cancer
          Andrea Miyahira, Ph.D
        • Women in Science
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • TESTICULAR, PENILE & RARE GU MALIGNANCIES
        • Testicular Cancer
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Pelvic Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
      • Urologic Catheters (Includes CAUTI)
        Diane K. Newman, DNP, ANP-BC, FAAN
  • Videos
    • Exclusives
      • Conferences
      • Exclusive Collaborations
      • Independent Medical Education
      • Covid-19
      • The Prostate Cancer Foundation
      • Health Policy in Urological Diseases
      • Disparities: Social Determinants of Health
      • Practice Guidelines Reviews
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Testicular Cancer
      • Endourology
    • Pelvic Health & Reconstruction
      • Pelvic Health & Reconstruction
  • Trials in Progress
    • Trials in Progress
      • Bladder Cancer
        • BOND-003 Cohort P
        • CORE-008
        • IMMORTAL
        • PIVOT-006
      • Kidney Cancer
        • RadiCal
        • SAMURAI
    • Middle Side
      • Prostate Cancer
        • ARAMON
        • ARASEC
        • ARASTEP
        • CLARIFY
        • ECLIPSE
        • ESCAPE
        • FORT
    • Right Side
      • Prostate Cancer
        • METANOVA
        • NRG-GU 0101
        • PROMISE
        • RTIRE
        • SECuRE
        • SHORTER
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • SUO 2024
      • SCS AUA 2024
      • ASTRO 2024
      • IBCN 2024
      • ESMO 2024
    • All Conferences
      • View All
    • Quick Takes
      • ESMO 2024
  • PCF
  1. UroToday Home
  2. Recent Abstracts
  3. Urologic Oncology

Prostate Cancer

Recent Abstracts
Sipuleucel-T in patients with metastatic castration-resistant prostate cancer: An insight for oncologists - Abstract August 16, 2011
Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer - Abstract August 16, 2011
Editor's Commentary - Circulating estradiol, but not testosterone, is a significant predictor of high-grade prostate cancer in patients undergoing radical prostatectomy August 16, 2011
Androgen deprivation therapy through bilateral orchiectomy: Increased metabolic risks - Abstract August 15, 2011
Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival : Results of a retrospective study - Abstract August 15, 2011
Insignificant prostate cancer: Charateristics and predictive factors - Abstract August 15, 2011
A phase III extension trial with a 1-Arm crossover from leuprolide to degarelix: Comparison of gonadotropin-releasing hormone agonist and antagonist effect on prostate cancer - Abstract August 15, 2011
Expanded Prostate Cancer Index Composite for Clinical Practice: Development and validation of a practical health related quality of life instrument for use in the routine clinical care of patients with prostate cancer - Abstract August 15, 2011
Regional collaboration to improve radiographic staging practices among men with early stage prostate cancer - Abstract August 15, 2011
B7-H3 over expression in prostate cancer promotes tumor cell progression - Abstract August 12, 2011
Single-fraction high dose rate brachytherapy and hypofractionated external beam radiation therapy in the treatment of intermediate-risk prostate cancer - Long term results - Abstract August 12, 2011
Circulating estradiol, but not testosterone, is a significant predictor of high-grade prostate cancer in patients undergoing radical prostatectomy - Abstract August 12, 2011
Association of census tract-level socioeconomic status with disparities in prostate cancer-specific survival - Abstract August 12, 2011
Locally recurrent prostate cancer after high-dose-rate brachytherapy: The value of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging in localizing tumors - Abstract August 12, 2011
Pathological findings following radical prostatectomy in patients who are candidates for active surveillance: Impact of varying PSA levels - Abstract August 12, 2011
Editor's Commentary - Phase II study of abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer displaying bone flare discordant with serologic response August 12, 2011
UroToday Slide Library - Introductory remarks: mTOR targeted agents August 12, 2011
Crawling wave detection of prostate cancer: Preliminary in vitro results - Abstract August 11, 2011
Influence of obesity on tumour volume in patients with prostate cancer - Abstract August 11, 2011
Patient reported outcomes of symptoms and quality of life among cancer patients treated with palliative pelvic radiation: A pilot study - Abstract August 11, 2011
Page 1382 of 1451
  • Start
  • Prev
  • 1377
  • 1378
  • 1379
  • 1380
  • 1381
  • 1382
  • 1383
  • 1384
  • 1385
  • 1386
  • Next
  • End
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2025 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free